• Corpus ID: 55469478

Nuclear magnetic resonance metabolomics and human liver diseases : The principles and evidence associated with protein and carbohydrate metabolism ( Review )

  title={Nuclear magnetic resonance metabolomics and human liver diseases : The principles and evidence associated with protein and carbohydrate metabolism ( Review )},
  author={Laurence le Moyec and Mohamed Nawfal Triba and Pierre Nahon and Nadia Bouchemal and Edith Hantz and Corentine Goossens and Roland Amathieu and Philippe Savarin},
During the last decade, metabolomics has become widely used in the field of human diseases. Numerous studies have demonstrated that this is a powerful technique for improving the understanding, diagnosis and management of various types of liver disease, such as acute and chronic liver diseases, and liver transplantation. Nuclear magnetic resonance (NMR) spectroscopy is one of the two most commonly applied methods for metabolomics. The aim of the present review was to investigate the results… 
1 Citations

Tables from this paper

Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
The metabonomic strategy performed excellently in predicting significant and advanced liver fibrosis in CHC patients, including those in the gray zone of APRI and FIB-4, which may contribute to reducing the need for these patients to undergo liver biopsy.


Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications.
The clinical point of view is considered to enlighten physicians on this new approach and emphasis its future use in clinical "routine" by focusing specifically on in vitro proton nuclear magnetic resonance spectroscopy based metabolomics approaches in human studies.
Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies.
The applicability of 1H high resolution magic angle spinning (HR-MAS) NMR spectroscopy in the biochemical profile determination of human liver needle biopsy samples for the characterization of metabolic alterations related to the severity of liver disease is demonstrated.
Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis.
It is found that metabolomic NMR analysis provides new insights into metabolic processes related to the severity of hepatic function impairment in cirrhosis, and other metabolites such as lactate, pyruvate, glucose, amino acids, and creatinine were significantly higher in patients with severe CLF than mild CLF.
Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy
It is demonstrated that statistical analysis of 1H-NMR spectra is able to distinguish between fibrotic and non-fibrotic patients suffering from HCV, representing a novel diagnostic application for NMR spectroscopy.
NMR and LC/MS‐based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis
The results suggested that these potential biomarkers identified appeared to have diagnostic and/or prognostic values for HCC, which deserve to be further investigated, and suggested that RF is a classification algorithm well suited for selection of biologically relevant features in metabolomics.
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
This review gathers the numerous markers proposed by studies using mass spectrometry and proton nuclear magnetic resonance spectroscopy and evaluates areas of consistency as well as discordance and predicts a high-performance non-invasive test able to diagnose early HCC and related conditions.
Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
This is the first study to identify similarly altered urine metabolic profiles of hepatocellular carcinoma in two etiologically and ethnically distinct populations, suggesting that altered metabolism as a result of tumorogenesis is independent of these two factors.
Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma
This technique‐driven review aims to demystify the metabolomics pathway, while also illustrating the potential of this technique, with recent examples of its application in HCC.